Grace Therapeutics, Inc. research brief
CIK 1444192
Generated Nov. 18, 2026, 12:54 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: PRINCETON New Jersey. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Aug. 11, 2026 · D · 0001123292-26-001084 · Source evidence
Reported offering amount: 9999998 USD. Reported amount sold: 9999998 USD.
- Feb. 25, 2025 · D · 0001140361-25-005827 · Source evidence
Reported offering amount: 30000203 USD. Reported amount sold: 14999985 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Grace Therapeutics, Inc. research brief,” CIK 1444192, retrieved Nov. 18, 2026, 12:54 a.m.. Cite the specific accessions used. No amounts have been summed.